Insights On Drug Development

  1. The Science Fueling Cell Culture Optimization For Biologic Therapies 5/18/2026

    Boost mAb titers by over 60% with an optimized intensified fed-batch process, no new equipment required. See the data.

  2. How To Advance Self-Administered Therapies 5/18/2026

    Scale your biologic fill-finish from vials to autoinjectors without disruption. See how integrated device assembly capabilities support every clinical phase through commercialization.

  3. Avoiding Regulatory Setbacks In OSD Development: Why Early Formulation Decisions Matter 5/18/2026

    Rushed OSD formulation decisions create costly downstream failures. Learn how strategic early-phase planning reduces CMC holds, scale-up risks, and regulatory delays.

  4. How Peptides Became Cornerstones Of Modern Medicine 5/18/2026

    Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.

  5. Strategic Early Material Generation For Accelerated Process Development 5/14/2026

    Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

  6. Accelerating Development Of A Unique Molecule To Treat Lung Cancer 5/14/2026

    Process development and optimization enabled efficient scale‑up of a complex lung cancer therapy, improving yields, reducing costs, and supporting rapid clinical and commercial progress.

  7. Advancing ADC Development Through Integrated ADME, DDI Strategies 5/8/2026

    Discover how tailored strategies, advanced technologies, and scientifically driven decision frameworks are accelerating the successful development and regulatory readiness of next-generation ADCs.

  8. Unlock The Potential Of GPEx® Lightning: Accelerate Your HEK Cell Line Development 5/8/2026

    Cut HEK cell line development to four months with 30% higher titers. GPEx® Lightning delivers faster, scalable biologics manufacturing. Access the full summary now.

  9. Streamlining Process Characterization Toward Successful Validation Campaigns 5/8/2026

    Compress your biologics process characterization timeline without sacrificing quality. Learn how FMEA, DoE, and platform approaches help you hit PPQ readiness faster while managing regulatory risk.

  10. A Systematic Approach To Assess Biologics Developability 5/8/2026

    Discover how a systematic, data-driven developability workflow can accelerate biologic formulation development, identify risks earlier, and optimize stability and manufacturability.